CIPLA.BO

Cipla Limited · Healthcare · Drug Manufacturers - General

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$12.05B

PE Ratio

25.43

EV to Ebitda

—

Earnings Yield

4.00%

Revenue (TTM)

$2.91B

Net Income (TTM)

$473.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

0.00%

Profit Margin

16.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$12.05B

Revenue TTM$2.91B

Shares Outstanding807.8M

Float498319830

Insider Ownership31.00%

Institutional Ownership40.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)0.00%

Rev Growth Est 1Y Forward0.09

EPS Growth (Quarterly YoY)-57.00%

EPS Growth Est Quarterly15.55

LT EPS Growth Estimates8.00%

Operations16 fields›

Revenue TTM$2.91B

Gross Margin TTM65.00%

Gross Margin (Quarterly)63.00%

Operating Margin TTM14.00%

Operating Margin (Quarterly)10.00%

Operating Expenses TTM$5.9M

Profit Margin TTM16.00%

Profit Margin (Quarterly)10.00%

Net Income TTM$473.8M

EPS TTM56.2

EPS (Quarterly)8.37

EBITDA Margin TTM23.00%

EBITDA TTM$663.7M

Capex % of Revenue TTM9.00%

Capital Expenditures$250.8M

FCF % of Revenue (Quarterly)12.00%

Efficiency1 fields›

ROA10.00%

Valuation8 fields›

P/E (TTM)25.43

P/E Forward23.64

PEG1.05

EV/Revenues (TTM)3.44

Price To Book3.51

Price to Tangible Book4.2

Earnings Yield4.00%

Payout Ratio37.00%

Liquidity9 fields›

Cash Per Share131.46

Current Ratio4.25

Cash & ST Assets$7.96B

Goodwill & Intangibles$53738.40T

Total Assets$4.19B

Total Liabilities$2.72B

Shareholders Equity$3.43B

Interest Expense$5.9M

Goodwill % of Assets13379670.00%

Yields3 fields›

Payout Ratio37.00%

Earnings Yield4.00%

Buyback Yield0.00%